These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 21654838)
41. Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells. Mukherjee N; Reuland SN; Lu Y; Luo Y; Lambert K; Fujita M; Robinson WA; Robinson SE; Norris DA; Shellman YG J Invest Dermatol; 2015 Mar; 135(3):842-850. PubMed ID: 25350317 [TBL] [Abstract][Full Text] [Related]
42. [Role of tumor microenvironment in the formation and progression of skin melanoma]. Olbryt M Postepy Hig Med Dosw (Online); 2013 May; 67():413-32. PubMed ID: 23756376 [TBL] [Abstract][Full Text] [Related]
43. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411 [TBL] [Abstract][Full Text] [Related]
46. Testing the cancer stem cell hypothesis in melanoma: the clinics will tell. Shakhova O; Sommer L Cancer Lett; 2013 Sep; 338(1):74-81. PubMed ID: 23073475 [TBL] [Abstract][Full Text] [Related]
47. Highlights of the 2012 Congress of the Society for Melanoma Research, 8-11 November 2012, Hollywood, CA. Vultur A; Webster M; Villanueva J; Herlyn D Melanoma Res; 2013 Jun; 23(3):237-40. PubMed ID: 23546222 [TBL] [Abstract][Full Text] [Related]
48. Stem cells, melanoma and cancer stem cells: the good, the bad and the evil? Menaa F; Houben R; Eyrich M; Broecker EB; Becker JC; Wischhusen J G Ital Dermatol Venereol; 2009 Jun; 144(3):287-96. PubMed ID: 19088701 [TBL] [Abstract][Full Text] [Related]
49. Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells. Peretz Y; Wu H; Patel S; Bellacosa A; Katz RA PLoS One; 2015; 10(2):e0116839. PubMed ID: 25642713 [TBL] [Abstract][Full Text] [Related]
50. Regulation of Cancer Stem Cell Self-Renewal by HOXB9 Antagonizes Endoplasmic Reticulum Stress-Induced Melanoma Cell Apoptosis via the miR-765-FOXA2 Axis. Lin J; Zhang D; Fan Y; Chao Y; Chang J; Li N; Han L; Han C J Invest Dermatol; 2018 Jul; 138(7):1609-1619. PubMed ID: 29408459 [TBL] [Abstract][Full Text] [Related]
58. Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma. Schnegg CI; Yang MH; Ghosh SK; Hsu MY Cancer Res; 2015 Apr; 75(8):1682-90. PubMed ID: 25769726 [TBL] [Abstract][Full Text] [Related]
59. Macrophage-tumor cell fusions from peripheral blood of melanoma patients. Clawson GA; Matters GL; Xin P; Imamura-Kawasawa Y; Du Z; Thiboutot DM; Helm KF; Neves RI; Abraham T PLoS One; 2015; 10(8):e0134320. PubMed ID: 26267609 [TBL] [Abstract][Full Text] [Related]
60. Improving cancer stem cells killing in malignant melanoma. Bergamaschi D Br J Dermatol; 2024 Apr; 190(5):615-616. PubMed ID: 38282338 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]